Trials / Completed
CompletedNCT02996084
MS PATHS Normative Sub-Study
Longitudinal Brain Volume Change (and Correlates) in Healthy Control Subjects: A Normative Sub-Study of Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 246 (actual)
- Sponsor
- Biogen · Industry
- Sex
- All
- Age
- 21 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this study is to determine the normative range of brain volume and brain volume change in healthy control (HC) participants whose age, race, and gender distribution is approximately matched to the age, race, and gender distribution of patients with Multiple Sclerosis (MS) enrolled in Study 888MS001. The secondary objective is to use the results of the primary endpoint to ensure consistency of brain volume measurements across MS PATHS centers.
Conditions
Timeline
- Start date
- 2017-12-12
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2016-12-19
- Last updated
- 2023-02-24
Locations
6 sites across 3 countries: United States, Germany, Spain
Source: ClinicalTrials.gov record NCT02996084. Inclusion in this directory is not an endorsement.